Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer
出版年份 2023 全文链接
标题
Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer
作者
关键词
-
出版物
SEMINARS IN CANCER BIOLOGY
Volume 96, Issue -, Pages 64-81
出版商
Elsevier BV
发表日期
2023-10-10
DOI
10.1016/j.semcancer.2023.10.002
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CRISPR–dCas12a-mediated genetic circuit cascades for multiplexed pathway optimization
- (2023) Yaokang Wu et al. Nature Chemical Biology
- A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment
- (2023) Xianguang Yang et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus
- (2023) Shikha Rani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The era of Cas12 and Cas13 CRISPR-based disease diagnosis
- (2022) Mandeep Singh et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells
- (2022) Zahra Noroozi et al. Scientific Reports
- Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
- (2022) Shuying Feng et al. Frontiers in Cell and Developmental Biology
- Extracellular Vesicles and Their Emerging Roles as Cellular Messengers in Endocrinology: An Endocrine Society Scientific Statement
- (2022) Carlos Salomon et al. ENDOCRINE REVIEWS
- Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9
- (2022) Lifang Xie et al. FEBS Journal
- Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020
- (2022) Citadel J. Cabasag et al. INTERNATIONAL JOURNAL OF CANCER
- Structural biology of CRISPR–Cas immunity and genome editing enzymes
- (2022) Joy Y. Wang et al. NATURE REVIEWS MICROBIOLOGY
- Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants
- (2022) Jon Arizti-Sanz et al. Nature Biomedical Engineering
- Encapsulating Cas9 into extracellular vesicles by protein myristoylation
- (2022) Joseph Andrew Whitley et al. Journal of Extracellular Vesicles
- A target expression threshold dictates invader defense and prevents autoimmunity by CRISPR-Cas13
- (2022) Elena Vialetto et al. Cell Host & Microbe
- CRISPR‐Cas‐based detection for food safety problems: Current status, challenges, and opportunities
- (2022) Yaru Li et al. COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY
- Progress of delivery methods for CRISPR-Cas9
- (2022) Wu Yang et al. Expert Opinion on Drug Delivery
- CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors
- (2022) Peter B Otoupal et al. NUCLEIC ACIDS RESEARCH
- The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy
- (2022) Kewen Qian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
- (2022) Qiurong Yang et al. Advanced Science
- Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
- (2022) Astrid Murumägi et al. BRITISH JOURNAL OF CANCER
- A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics
- (2021) Yan Sheng et al. BIOSENSORS & BIOELECTRONICS
- Overcoming PARPi resistance: preclinical and clinical evidence in ovarian cancer
- (2021) M. Chiappa et al. DRUG RESISTANCE UPDATES
- A Versatile Platform for Generating Engineered Extracellular Vesicles with Defined Therapeutic Properties
- (2021) Kevin Dooley et al. MOLECULAR THERAPY
- CRISPR technologies for precise epigenome editing
- (2021) Muneaki Nakamura et al. NATURE CELL BIOLOGY
- Extracellular vesicles versus synthetic nanoparticles for drug delivery
- (2021) Kenneth W. Witwer et al. Nature Reviews Materials
- A Simple and Quick Method for Loading Proteins in Extracellular Vesicles
- (2021) Sara Busatto et al. Pharmaceuticals
- Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy
- (2021) Lili Cheng et al. BIOMATERIALS
- Synthetic Lethality in Ovarian Cancer
- (2021) Akshaya Chandrasekaran et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
- (2021) America Campos et al. Cancers
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The promise and challenge of therapeutic genome editing
- (2020) Jennifer A. Doudna NATURE
- A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy
- (2020) Jing Fan et al. ACS Synthetic Biology
- Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
- (2020) Abishek Wadhwa et al. Pharmaceutics
- Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
- (2020) Peter Gee et al. Nature Communications
- CRISPRi-dCas12a: A dCas12a-Mediated CRISPR Interference for Repression of Multiple Genes and Metabolic Engineering in Cyanobacteria
- (2020) Sun Young Choi et al. ACS Synthetic Biology
- CRISPR/Cas13a Powered Portable Electrochemiluminescence Chip for Ultrasensitive and Specific MiRNA Detection
- (2020) Ting Zhou et al. Advanced Science
- Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib
- (2020) Cong He et al. EXPERIMENTAL CELL RESEARCH
- Gene Editing by Extracellular Vesicles
- (2020) Dmitry Kostyushev et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
- (2020) Jialang Zhuang et al. NUCLEIC ACIDS RESEARCH
- Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
- (2020) Anne M. Macpherson et al. Journal of Clinical Medicine
- Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA
- (2020) Maturada Patchsung et al. Nature Biomedical Engineering
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy
- (2020) Jinliang Gao et al. Molecular Therapy-Oncolytics
- Synthetic lethality guiding selection of drug combinations in ovarian cancer
- (2019) Andreas Heinzel et al. PLoS One
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
- (2019) Benjamin P. Kleinstiver et al. NATURE BIOTECHNOLOGY
- Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression
- (2019) Tamaki Yahata et al. CANCER SCIENCE
- The next generation of CRISPR–Cas technologies and applications
- (2019) Adrian Pickar-Oliver et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
- (2019) Shayesteh R. Ferdosi et al. Nature Communications
- Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration
- (2019) Sanne E. Klompe et al. NATURE
- Extracellular vesicles: a new communication paradigm?
- (2019) Graça Raposo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- RNA-guided DNA insertion with CRISPR-associated transposases
- (2019) Jonathan Strecker et al. SCIENCE
- Olaparib in the treatment of ovarian cancer
- (2019) Christina R. Washington et al. Future Oncology
- Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy
- (2019) Zhanzhan Zhang et al. ADVANCED MATERIALS
- Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis
- (2019) Wei Zhang et al. BMC CANCER
- Immunogenicity of Cas9 Protein
- (2019) Aditi Mehta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
- (2019) Xiaojing Shi et al. MOLECULAR THERAPY
- CRISPR/Cas13a Signal Amplification Linked Immunosorbent Assay for Femtomolar Protein Detection
- (2019) Qian Chen et al. ANALYTICAL CHEMISTRY
- The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model
- (2019) Weisong Duan et al. GENE THERAPY
- Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
- (2019) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
- (2019) Daelyn Y. Richards et al. Molecular Therapy-Methods & Clinical Development
- Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy
- (2018) Tian Tian et al. BIOMATERIALS
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- dCas9: A Versatile Tool for Epigenome Editing
- (2018) Daan J.W. Brocken et al. CURRENT ISSUES IN MOLECULAR BIOLOGY
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
- (2018) Yoshizumi Ishino et al. JOURNAL OF BACTERIOLOGY
- A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer
- (2018) Yan Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
- (2018) Haiying Zhang et al. NATURE CELL BIOLOGY
- Field-deployable viral diagnostics using CRISPR-Cas13
- (2018) Cameron Myhrvold et al. SCIENCE
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
- (2018) Jonathan S. Gootenberg et al. SCIENCE
- CRISPR/Cas13 as a Tool for RNA Interference
- (2018) Zahir Ali et al. TRENDS IN PLANT SCIENCE
- Efficient RNA drug delivery using red blood cell extracellular vesicles
- (2018) Waqas Muhammad Usman et al. Nature Communications
- VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
- (2018) Claudia Montagna et al. Molecular Therapy-Nucleic Acids
- Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
- (2018) Yao Lin et al. Advanced Science
- Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris
- (2018) Sarah Caruso et al. Frontiers in Immunology
- The Origin and Functions of Exosomes in Cancer
- (2018) Chitra Rajagopal et al. Frontiers in Oncology
- Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
- (2018) D.C. Luther et al. Expert Opinion on Drug Delivery
- Exosomal microRNAs as tumor markers in epithelial ovarian cancer
- (2018) Chi Pan et al. Molecular Oncology
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Circulating Extracellular Vesicles in Human Disease
- (2018) Ravi Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Cas guides the future of genetic engineering
- (2018) Gavin J. Knott et al. SCIENCE
- mRNA as novel technology for passive immunotherapy
- (2018) Thomas Schlake et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Immunotherapies based on PD-1/PD-L1 pathway inhibitors in ovarian cancer treatment
- (2018) A. Pawłowska et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
- (2018) Lee A. Campbell et al. MOLECULAR THERAPY
- In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9
- (2018) Zhelong Li et al. NANO LETTERS
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation
- (2018) Duško Lainšček et al. ACS Synthetic Biology
- Viral vector-based delivery of CRISPR/Cas9 and donor DNA for homology directed repair in an in vitro model for canine hemophilia B
- (2018) Jian Gao et al. Molecular Therapy-Nucleic Acids
- APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner
- (2017) Yuyin Yi et al. GYNECOLOGIC ONCOLOGY
- Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
- (2017) Mauro Cataldi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
- (2017) Seung Min Kim et al. JOURNAL OF CONTROLLED RELEASE
- Genome editing via delivery of Cas9 ribonucleoprotein
- (2017) Mark A. DeWitt et al. METHODS
- Engineered Exosomes as Vehicles for Biologically Active Proteins
- (2017) Ulrich Sterzenbach et al. MOLECULAR THERAPY
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
- (2017) Fengmei Pi et al. Nature Nanotechnology
- Diversity and evolution of class 2 CRISPR–Cas systems
- (2017) Sergey Shmakov et al. NATURE REVIEWS MICROBIOLOGY
- CRISPR-Cas: Adapting to change
- (2017) Simon A. Jackson et al. SCIENCE
- Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
- (2017) Guannan Zhao et al. Oncotarget
- Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
- (2017) Wenying Huo et al. Journal of Cancer
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- Antiangiogenic Therapies in Epithelial Ovarian Cancer
- (2017) Deanna G. K. Teoh et al. Cancer Control
- PARP inhibitors in ovarian cancer
- (2016) J. A. Ledermann ANNALS OF ONCOLOGY
- Extracellular vesicles as novel carriers for therapeutic molecules
- (2016) Nambin Yim et al. BMB Reports
- microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
- (2016) Xiaodi Li et al. BRITISH JOURNAL OF CANCER
- The immunoglobulin-like superfamily member IGSF3 is a developmentally regulated protein that controls neuronal morphogenesis
- (2016) Alessia Usardi et al. Developmental Neurobiology
- Immune checkpoint inhibition in ovarian cancer
- (2016) Junzo Hamanishi et al. INTERNATIONAL IMMUNOLOGY
- Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes
- (2016) Sean Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The biology and function of exosomes in cancer
- (2016) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity
- (2016) Josh Tycko et al. MOLECULAR CELL
- Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
- (2016) Xiaodan Meng et al. Oncotarget
- Targeting folate receptor alpha for cancer treatment
- (2016) Anthony Cheung et al. Oncotarget
- A role for peptides in overcoming endosomal entrapment in siRNA delivery — A focus on melittin
- (2015) Kirk K. Hou et al. BIOTECHNOLOGY ADVANCES
- The CRISPR/Cas9 system for plant genome editing and beyond
- (2015) Luisa Bortesi et al. BIOTECHNOLOGY ADVANCES
- The structural biology of CRISPR-Cas systems
- (2015) Fuguo Jiang et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- The Effect of Glucose on the Release and Bioactivity of Exosomes From First Trimester Trophoblast Cells
- (2015) Gregory E. Rice et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
- (2015) Michael Boettcher et al. MOLECULAR CELL
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Inducible in vivo genome editing with CRISPR-Cas9
- (2015) Lukas E Dow et al. NATURE BIOTECHNOLOGY
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes
- (2015) Ikuhiko Nakase et al. Scientific Reports
- Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
- (2014) Charles P. Lai et al. ACS Nano
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
- (2014) Alexandra E. Briner et al. MOLECULAR CELL
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
- (2014) Dirk Heckl et al. NATURE BIOTECHNOLOGY
- Emerging role of extracellular vesicles in inflammatory diseases
- (2014) Edit I. Buzas et al. Nature Reviews Rheumatology
- Cas9 Targeting and the CRISPR Revolution
- (2014) R. Barrangou SCIENCE
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- PARP inhibition and synthetic lethality in ovarian cancer
- (2014) Ramez N Eskander et al. Expert Review of Clinical Pharmacology
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- Immune Sensing of DNA
- (2013) Søren R. Paludan et al. IMMUNITY
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
- (2013) Brian M. Nolen et al. Molecular Diagnosis & Therapy
- Cas9 as a versatile tool for engineering biology
- (2013) Prashant Mali et al. NATURE METHODS
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- CRISPR interference (CRISPRi) for sequence-specific control of gene expression
- (2013) Matthew H Larson et al. Nature Protocols
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Exosomal Signaling during Hypoxia Mediates Microvascular Endothelial Cell Migration and Vasculogenesis
- (2013) Carlos Salomon et al. PLoS One
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
- (2012) Ting Gui et al. Cancer Epidemiology
- Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
- (2012) Shin-ichiro Ohno et al. MOLECULAR THERAPY
- Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system
- (2012) Joe Bondy-Denomy et al. NATURE
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts
- (2011) Jung Ah Cho et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Evolution and classification of the CRISPR–Cas systems
- (2011) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Exosomes: Extracellular organelles important in intercellular communication
- (2010) Suresh Mathivanan et al. Journal of Proteomics
- Diversity of CRISPR loci in Escherichia coli
- (2010) MICROBIOLOGY-SGM
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
- (2010) Dongmei Sun et al. MOLECULAR THERAPY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Current Review of Targeted Therapeutics for Ovarian Cancer
- (2010) Susana M. Campos et al. Journal of Oncology
- Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
- (2009) Jianghong Li et al. BMC CANCER
- First-line treatment of advanced ovarian cancer: current research and perspectives
- (2009) Claudia Marchetti et al. Expert Review of Anticancer Therapy
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Antiangiogenic drugs in ovarian cancer
- (2008) G C Kumaran et al. BRITISH JOURNAL OF CANCER
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More